N-(5-Bromopentyl)phthalimide

Catalog No. :
ACCDOT957
CAS No. :
954-81-4
Molecular Formula :
C13H14BrNO2
Molecular Weight :
296.16

IUPAC Name:2-(5-bromopentyl)isoindoline-1,3-dione

N-(5-Bromopentyl)phthalimide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$70.00Login to see priceIn stockIn stock
100g95%$209.00Login to see priceIn stockIn stock
500g95%$941.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-Bromopentyl)phthalimide
IUPAC Name2-(5-bromopentyl)isoindoline-1,3-dione
MDL No.MFCD00060522
Molecular FormulaC13H14BrNO2
Molecular Weight296.16
SMILESO=C1N(CCCCCBr)C(C2=C1C=CC=C2)=O
InChI KeyQKVHAKICMNABGB-UHFFFAOYSA-N
SynonymA845313 | B4986 | CS-0019374 | N-(5-Bromopentyl)phthalimide | N-(5-Bromopentyl)-phthalimide | SR-01000325457 | 2-(5-bromopentyl)isoindoline-1,3-dione | STR07349 | SB64074 | 1H-Isoindole-1,3(2H)-dione, 2-(5-bromopentyl)- | 5-phthalimidopentyl bromide | EN3
CAS No.954-81-4
PubChem CID136770

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCDOT957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACCDOT957 route product structure diagram
    ACCDOT957954-81-4 In Stock
Inquiry

2. ACCDOT957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACCDOT957 route product structure diagram
    ACCDOT957954-81-4 In Stock
Inquiry

Comments (0)